Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $6.2100 (9.52%) ($6.2100 - $6.2100) on Tue. Jan. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.43% (three month average) | RSI | 0 | Latest Price | $6.2100(9.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC advances 1.7% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) QQQ(20%) HYG(19%) JNK(19%) IVW(17%) IWF(16%) | Factors Impacting ANPC price | ANPC will decline at least -7.715% in a week (0% probabilities). IGOV(-23%) VIXM(-16%) UNG(-12%) TLT(-9%) VXX(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -7.715% (StdDev 15.43%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.91(5.08%) | 10 Day Moving Average | $5.73(8.38%) | 20 Day Moving Average | $5.65(9.91%) | To recent high | -11.9% | To recent low | 24% | Market Cap | $53m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |